InvestorsHub Logo
Followers 26
Posts 4067
Boards Moderated 0
Alias Born 12/26/2018

Re: wsbc post# 252982

Sunday, 12/30/2018 2:02:00 PM

Sunday, December 30, 2018 2:02:00 PM

Post# of 402945

Leo's lowest current offer is indicating that B-OM is worth $150M/yr



Where did you see this? $500M/yr was the lowest estimate I have seen.

Kevetrin is very hard to value. Given the enormous deals on pre-clinical cancer drugs we've been seeing over the past decade, I think Kevetrin is worth well over $100 million. I don't know what Leo values it at and I don't know what BP values it at though. It's too hard for me to consider it any thing other than an upside, wild card sweetener for a full company buyout.

I'd love to see a billion dollar deal done on B-OM/IBD. It's certainly very possible but it takes a bit more faith to get there. The numbers I suggested run significantly higher than the doom/gloom being posted here and are still easily digestible by all but the most negative skeptics. I don't think we could get $1 billion in a full takeout at this time.

Here's to hoping for the upside!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News